Table 1 Patient characteristics at follow-up visita.
Total cohort (n = 203) | |
|---|---|
Age (y) | 58 (14) |
Male gender n (%) | 85 (41.9) |
BMI (kg/m2) | 28.1 (24.4–31.2) |
Smokers (incl.ex) n (%)* | 107 (52.7) |
Post-bd FEV1/FVC < 0.7 and pack-y ≥ 10 n (%) | 34 (16.7) |
Smoking history, pack-y | 16 (7–30) |
Total IgE (kU/l) | 61 (24–163) |
Daily ICS in use n (%) | 155 (76.4) |
Blood eosinophils (x109/l) | 0.17 (0.10–0.27) |
Pre-bd FEV1% | 86 (76–96) |
Pre-bd FVC % | 96 (87–106) |
Pre-bd FEV1/FVC | 0.73 (0.66–0.79) |
Post-bd FEV1% | 90 (80–98) |
Post-bd FVC % | 99 (88–107) |
Post-bd FEV1/FVC | 0.75 (0.69–0.80) |
DlCO, % | 93 (18) |
DlCO/VA, % | 95 (16) |
AQ20 score | 4 (2–7) |
